Speclipse

Provider of molecular spectroscopy systems for early-stage skin cancer detection

placeSeongnam-si, Gyeonggi-do, South Korea calendar_todayFounded 2015 groups12 employees language speclipse.com

Investor mix

12 investors on record; lead investors include Mega Investment, InterVest, SBVA, Signite Partners.

Investor typeCountShare
Venture capital758%
Private equity18%
Accelerator & incubator18%
Other / undisclosed325%
Coming soon